Generics, Super-Generics and Patent Strategies

http://www.alrise.de

ALRISE develops controlled-release depot formulations for pharma and generics companies. Using its worldwide-patented ImSus® technology, protein, peptide or small molecule drugs are encapsulated in biodegradable polymeric microparticles. Alrise’s development programs include both new drugs (NCEs) and approved drugs that are reformulated for the purpose of product-lifecycle-management or as super-generics, respectively.

http://www.bactimm.com

Farmalyse & Bactimm are pharmaceutical contract laboratories offering a range of client specific pharmaceutical services. With our experience of over 12 years & expertise in Qualified Person services, Laboratory Investigations & the EU Pharmaceutical Gateway , we provide end-end customised solutions for Import, Batch Release & Supply Chain Management (country specific & pan-European operations) for Generics, Injectibles and Cytostatics.

http://www.kmob.com

Knobbe Martens Olson & Bear LLP, currently the third largest IP firm in the United States, practices exclusively in the area of intellectual property law including patents, trademarks, copyrights, trade secrets, rights of publicity, unfair competition, and related litigation and licensing. At present, the firm is composed of more than 275 lawyers and scientists, nearly all of whom hold undergraduate or graduate degrees in either engineering or the technical sciences. Services are provided to clients throughout the United States and the world.

http://www.pharmaniaga.com

Pharmaniaga Berhad, a member of the UEM Group, is an investment holding company listed in the Main Board of Bursa Malaysia. The Pharmaniaga Group’s core businesses are generic pharmaceuticals manufacturing, research and development, marketing and sales, warehousing and distribution of pharmaceutical and medical products as well as supply, trading and installation of medical and hospital equipment. The capabilities of its two manufacturing plants allow the Pharmaniaga Group to deliver on its commitment to bring quality, affordable medicines to the community. One plant is equipped with production facilities for solids, liquids, “cephalosporin dry powder” injectables and “beta-lectam” antibiotics, together with state-of-the-art quality control and assurance laboratories, and modern research and development facilities; while the other plant is poised to be the low cost supplier of Small Volume Injectables (SVI) products in vials and ampoules to the regulated markets of Europe and the US. The Group’s manufacturing arm offers high quality and cost competitive contract manufacturing services, supported by its regulatory services, sales & marketing capabilities and distribution network. With a vision to be the premier Malaysian pharmaceuticals company, Pharmaniaga is guided by its philosophy of ‘doing business with a conscience’ and empowered by its mission of enriching life together, making it your ideal sourcing partner in this region.